SCHEMBL3050243

SCHEMBL3050243

COc1nc(N)c2c(n1)CCN(c1ccc(Cl)cc1)C2=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 2/20 0.39
SMN1; SMN2 Q16637 3/20 0.36
MAPT P10636 2/20 0.36
DGAT1 O75907 5/20 0.36
F10 P00742 1/20 0.35
ALDH1A1 P00352 2/20 0.35
GAA P10253 1/20 0.35
HPGD P15428 1/20 0.35
POLB P06746 1/20 0.34
CYP3A4 P08684 2/20 0.33
DPP8 Q6V1X1 1/20 0.33
DPP9 Q86TI2 1/20 0.33
GRM5 P41594 2/20 0.33
DRD2 P14416 1/20 0.33
DRD4 P21917 1/20 0.33
PDE4A P27815 1/20 0.33
PDE4B Q07343 1/20 0.33
PDE4C Q08493 1/20 0.33
PDE4D Q08499 1/20 0.33
MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3713246 0.88 C5AR1 (0.39) DPP4SMN1; SMN2DGAT1F10ALDH1A1
SCHEMBL3057537 0.88 DGAT1 (0.36) DPP4DGAT1F10GRM5PDE4A
SCHEMBL3049764 0.88 GRM5 (0.37) DPP4MAPTDGAT1ALDH1A1GAA
SCHEMBL3045044 0.87 DPP4 (0.38) DPP4SMN1; SMN2MAPTDGAT1
SCHEMBL3053703 0.86 DGAT1 (0.37) DPP4MAPTDGAT1F10ALDH1A1
SCHEMBL3047616 0.86 DGAT1 (0.47) DGAT1F10
SCHEMBL3054153 0.85 F10 (0.40) DGAT1F10CYP1A2
SCHEMBL3042466 0.85 DGAT1 (0.52) DGAT1
SCHEMBL3050376 0.85 ALDH1A1 (0.42) DGAT1F10ALDH1A1HPGDPOLB
SCHEMBL3054040 0.84 DGAT1 (0.38) DPP4DGAT1PDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010089686-A1 4-AMINO-7,8-DIHYDROPYRIDO[4,3-D]PYRIMIDIN-5(6H)-ONE DERIVATIVES PFIZER INC. (US) 2010-08-12 WO disclosed
US-20100197591-A1 4-AMINO-7,8-DIHYDROPYRIDO[4,3-d]PYRIMIDIN-5(6H)-ONE DERIVATIVES PFIZER INC 2010-08-05 US disclosed
US-20100197591-A1 4-AMINO-7,8-DIHYDROPYRIDO[4,3-d]PYRIMIDIN-5(6H)-ONE DERIVATIVES PFIZER INC 2010-08-05 US disclosed
US-20100197591-A1 4-AMINO-7,8-DIHYDROPYRIDO[4,3-d]PYRIMIDIN-5(6H)-ONE DERIVATIVES PFIZER INC 2010-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197591-A1 4-AMINO-7,8-DIHYDROPYRIDO[4,3-d]PYRIMIDIN-5(6H)-ONE DERIVATIVES CDK7, DPYD, DHFR DPP4 141/4885SMN1; SMN2 2217/4885MAPT 2605/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.